AI

AstraZeneca has identified an additional target for its idiopathic pulmonary fibrosis (IPF) pipeline using an AI system designed by drug discovery company BenevolentAI. It is now the third target from that collaboration that has been identified using BenevolentAI’s platform. AstraZeneca is using the company’s Benevolent Platform across two disease areas – IPF and chronic kidney […]

Listen to this article on the DDW Podcast: Exploitation of microbiome science will unlock multiple commercial opportunities across a number of industries including life sciences. But there is a need for more effective data and process management to get the best from microbiome data, according to Dr Sven Sewitz, Director of Biodata Innovation at Eagle Genomics. […]

Ahead of SLAS Europe May 24-27, 2022, in Dublin, Jill Hronek, SLAS Director, Marketing & Communications, shares how the SLAS community responded to the unprecedented need for laboratory automation internationally, and reflects on the conference theme, ‘Where Imagination Inspires Innovation’. Welcome back to the SLAS Europe Conference and Exhibition; it seems like a very long […]

Listen to this article on the DDW Podcast: With Covid-19 taking so much of the drug discovery and development’s focus over the last two years, it has been easy to overlook other areas within the sector that deserve our attention. With Q1 on its way out, Lu Rahman highlights the technology that will play a valuable […]

Artificial intelligence (AI) company BenevolentAI and not-for-profit R&D organisation Drugs for Neglected Disease initiative (DNDi) have launched a joint research project to tackle dengue, one of the world’s most prevalent infectious diseases.  Dengue represents one of the top 10 threats to global public health worldwide. Despite an estimated 390 million infections each year in over […]

Artificial intelligence (AI) company X-Chem has announced that its drug discovery platform XD3 is now available to biopharma partners and clients. XD3 is the company’s small molecule drug discovery platform and combines data generated through DNA-encoded library (DEL) screening, along with analytical and predictive capabilities offered by A-Chem’s AI platform, Artemis AI. The end-to-end platform […]

Noor Shaker, the Senior Vice President and General Manager for DNA technology company X-Chem, has been named a winner in the Artificial Intelligence Excellence Awards programme from Business Intelligence Group.   Shaker was one of six receiving an individual award from Business Intelligence Group, which recognises people and organisations applying artificial intelligence (AI) to solve real-world problems. Shaker […]

News round-up by DDW’s Megan Thomas for 4-8 April   When considering trends in the drug discovery industry, the use of technology to advance treatments and therapeutics is consistently observed. DDW rounds up five of this week’s top news stories which reveal this theme of technology, AI and biotechnology.   1. Jumpcode Genomics launches tech to improve […]

Artificial intelligence (AI) company Iktos has announced a collaboration with Ono Pharmaceuticals focused on expediting drug discovery for pre-clinical candidates.   The collaboration will see Iktos apply its de novo ligand and structure-based generative modelling technologies and software Makaya to complement Ono’s drug discovery capabilities. More so, Iktos will supply its AI-based retrosynthesis analysis and planning […]

Dr Anton Yuryev, Professional Services Director at  Elsevier explores how a project utilising artificial intelligence is helping discover drugs for a rare type of cancer.  Artificial Intelligence (AI) has considerable potential in the life sciences and healthcare sectors, where it is increasingly contributing to R&D breakthroughs. With its capacity to reduce the time spent processing data, improve […]

Listen to this article on the DDW Podcast: In the exclusive DDW & SLAS2022 supplement published ahead of SLAS2022 in Boston, US on 5-9 February, Daniel Rines, Senior Director at Strateos, shares with DDW how his role, artificial intelligence (AI), the work of Strateos and the Covid-19 pandemic have impacted the future of the lab.  Daniel Rines’ focus at Strateos is R&D Strategy. He explains: “At Strateos, […]

Listen to this article on the DDW Podcast: Joshua Kangas, an educator in the Computational Biology Department of Carnegie Mellon University, is helping to shape the minds of future lab specialists. He tells Megan Thomas what he believes the lab of the future will look like in this exclusive DDW & SLAS2022 supplement ahead of SLAS2022 in Boston, US on 5-9 […]

Listen to this article on the DDW Podcast: Dr David Walt, a professor at Harvard Medical School who runs labs at both Brigham and Women’s Hospital and the Wyss Institute at Harvard University, shares his thoughts on the drug discovery industry and what the pandemic has taught us about lab automation in the Winter issue of […]

TetraScience resolves root cause scientific data problems with a cloud-native platform, purpose-built to benefit scientists and data scientists, who use Tetra Data for automation and ML/AI. This paid-for advertorial by TetraScience appeared in the DDW / SLAS supplement in DDW Volume 23, Issue 1 – Winter 2021/22  Technology drives the value of scientific inquiry and outcomes. There continues to be brilliant […]

Sanofi and Exscientia have announced a research collaboration and license agreement to develop up to 15 novel small molecule candidates across oncology and immunology, leveraging Exscientia’s end-to-end AI-driven platform utilising actual patient samples.   Background  The companies have been working together since 2016 and in 2019, Sanofi in-licensed Exscientia’s novel bispecific small molecule candidate capable of targeting two distinct targets in inflammation […]

Machine learning (ML) holds the promise to revolutionise drug discovery. By integrating vast datasets into predictive models, ML will help researchers arrive at the optimal candidate compounds more quickly, disrupting the long cycle times of preclinical discovery research. DEL technology is unmatched in its ability to produce ultra-large datasets. By harnessing the power of next-generation […]